Crizotinib for ALK rearrangement-positive non-small cell lung cancer patients with central nervous system metastasis
2019 ◽
Vol 21
(10)
◽
pp. 1424-1431
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8059-8059
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7566-7566
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 8082-8082
◽
Keyword(s):